# Sartorius

Sartorius is a Corporate Investor based in Göttingen, Germany.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Göttingen, Germany
- **Region:** Europe
- **Address:** Otto-Brenner-Str. 20, 37079 Göttingen, Germany
- **Founded:** 1870
- **Assets under management:** Undisclosed
- **Website:** www.sartorius.com
- **LinkedIn:** https://de.linkedin.com/company/sartorius
- **Wikidata:** Q175835

## Regulatory record

- **Reports private funds:** No

## About

Sartorius offers solutions for the biopharmaceutical industry and laboratories, from drug discovery and development to production platforms for biomanufacturing.

## Sectors

- Life Sciences
- Biopharma
- Lab Equipment

## Offices

- Aubagne, France
- Illkirch, France
- Marlborough, USA
- Freiburg, Germany

## People

- Florian Funck — CFO and Member of the Executive Board

## Questions

### Who runs investment decisions at Sartorius?

Operational and capital allocation decisions sit with the executive board, whose members include CFO Florian Funck. The Supervisory Board, chaired by Lothar Kappich — executor of the Horst Sartorius estate — provides governance oversight. The founding family's three daughters, Karin Sartorius-Herbst, Christine Franken, and Ulrike Baro, exercise influence through their major shareholdings rather than executive roles.

### What is Bio-Rad Laboratories' relationship to Sartorius?

Bio-Rad Laboratories holds roughly 38% of Sartorius AG's ordinary shares, making it the largest single minority investor. This strategic stake gives Bio-Rad significant governance weight alongside the Sartorius family daughters and shapes the company's orientation toward the life sciences supply chain that both firms serve.

### Does the Sartorius family still control the company?

The family retains substantial economic ownership through Karin Sartorius-Herbst, Christine Franken, and Ulrike Baro, all daughters of the late Horst Sartorius. Day-to-day control rests with a non-family executive board, while family interests are represented through the Supervisory Board chaired by longtime family executor Lothar Kappich.

### How does Sartorius deploy capital?

Sartorius invests primarily as an operating company, channeling capital into production capacity expansion, R&D facilities, and acquisitions that extend its bioprocessing and laboratory equipment portfolio. Recent expansions include a cell and gene therapy competence center in Freiburg, Germany, and a bioprocess innovation center in Marlborough, USA.

## Related profiles

- [Sarsia](https://altss.com/profile/sarsia-management)
- [Sarus Select Capital](https://altss.com/profile/sarus-select-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/sartorius

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology